Back to Search Start Over

Media content about vaccines in the United States and Canada, 2012–2014: An analysis using data from the Vaccine Sentimeter.

Authors :
Powell, Guido Antonio
Zinszer, Kate
Verma, Aman
Bahk, Chi
Madoff, Lawrence
Brownstein, John
Buckeridge, David
Source :
Vaccine. Dec2016, Vol. 34 Issue 50, p6229-6235. 7p.
Publication Year :
2016

Abstract

Background A system for monitoring vaccine-related media content was previously developed and studied from an international perspective. This monitoring approach could also have value at a regional level, but it has yet to be evaluated at this scale. We examined regional patterns of vaccine-related media topics and sentiment in the US and Canada. Methods We extracted vaccine-relevant US and Canadian online media reports between June 2012 and October 2014 from the Vaccine Sentimeter, a HealthMap-based automated media monitoring system for news aggregators and blogs. We analyzed regional distributions of reports about vaccines, categories (i.e., topics), sentiment, and measles outbreaks. Findings The Vaccine Sentimeter captured 10,715 reports during the study period. Negative sentiment was highest in reports about vaccine safety (47%), Hepatitis B (19%), and Vermont (18%). Analyses of measles outbreaks revealed geographical variation in media content. For example, religious beliefs were mentioned in 27% of measles reports in Texas and 22% of British Columbia reports, but there were no references to religion in media on measles from California. Interpretations A regional analysis of online sentiment towards vaccine can provide insights that may give US and Canadian public health practitioners a deeper understanding of media influences on vaccine choices in their regions and consequently lead to more effective public health action. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
0264410X
Volume :
34
Issue :
50
Database :
Academic Search Index
Journal :
Vaccine
Publication Type :
Academic Journal
Accession number :
119773538
Full Text :
https://doi.org/10.1016/j.vaccine.2016.10.067